U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector transforms.
Related Posts
This is the spot for a tactical bounce, says BTIG’s Jonathan Krinsky
The S&P 500 is on track for its worst day of the year, but that means it’s time for investors to dig in, the technician […]
Supreme Court allows Hawaii climate change lawsuit to move forward
The companies appealed after the Hawaii Supreme Court ruled that claims for damages could move forward.
Trump and Fed Chair Powell could be set on a collision course over interest rates
Though Powell became Fed chair in 2018, after Trump nominated him for the position, the two clashed often about the direction of interest rates.